247083 Testing the Feasibility of Performance Measures for Medication Assisted Treatment for Substance Use Disorders in the Public Sector

Monday, October 31, 2011: 3:50 PM

Sean J. Haley, PhD, MPH , Health and Nutrition Sciences, Brooklyn College & CUNY School of Public Health, Brooklyn, NY
Kimberly Johnson, MBA , NIATx, University of Wisconsin, Madison, WI
Henrick Harwood , National Association of State Alcohol and Drug Abuse Directors, Washington, DC
It is expected coverage for substance use disorders will expand under the Patient Protection and Affordable Care Act. In turn, it is also expected that there will be an uptake in the use of medication assisted treatment (MAT) under both public payors and private insurers as a standard of care. The intent of this study was to describe the development of national performance measures for MAT as well as 5 States' ability to extract public data to calculate the draft measures. Generally, of the 5 States that participated in the study, most were able to capture data and report on measures related to opioid medications. Amongst opioid treatment patients, States were better at capturing information about methadone than buprenorphine. Unlike opioid MAT, with one exception, States' ability to capture services related to alcohol medications appeared quite limited. In addition, States appeared more able to capture measures that align with earlier stages in the MAT process but were more challenged when patients taper or stop medication maintenance. If the treatment of substance use disorders is to continue to be provided through traditional specialty care programs, there is a need for a much stronger Federal role to support the implementation of data infrastructures that can monitor evidence-based treatment services for public clients.

Learning Areas:
Administration, management, leadership
Chronic disease management and prevention
Public health administration or related administration
Public health or related laws, regulations, standards, or guidelines
Public health or related organizational policy, standards, or other guidelines
Systems thinking models (conceptual and theoretical models), applications related to public health

Learning Objectives:
Describe the development of a set of 15 performance measures for medication assisted treatment. Explain why it was important to test the feasibility of States' data systems to extract the necessary data elements Explain the results of the feasibility test. Discuss the implications for States' capacity to adopt use performance measures to improve treatment quality for medication assisted treatment.

Keywords: Substance Abuse Treatment, Health Reform

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I was the principal investigator for this study. I completed a post-doc at Treatment Research Institute under A. Thomas McLellan, Ph.D., in substance abuse treatment policy research and was a NIAAA trainee as a Ph.D. student/candidate at the Heller School at Brandeis University under Connie Horgan, Ph.D.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.